Is Revvity, Inc. overvalued or undervalued?

As of 22 August 2025, the valuation grade for Revvity, Inc. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued based on its metrics, which include a P/E ratio of 33, an EV to EBITDA of 15.29, and a PEG ratio of 3.05. In comparison, Hologic, Inc. has a fair valuation with a P/E of 21.83, while The Cooper Companies, Inc. is categorized as expensive with a P/E of 34.28.
Revvity's stock has significantly underperformed against the S&P 500, with a year-to-date return of -21.37% compared to the S&P 500's 12.22%. This trend of underperformance is further highlighted by a 5-year return of -25.75% against the S&P 500's impressive 96.61%, reinforcing the notion that Revvity, Inc. is overvalued in the current market context.